Bi­cy­cle rais­es $61M in down­sized IPO, join­ing fel­low biotechs on Nas­daq who have hauled in $1.6B col­lec­tive­ly

A splashy syn­di­cate, some big name part­ner­ships and a tech­nol­o­gy de­signed to de­liv­er a ther­a­peu­tic pay­load more pre­cise­ly have en­ticed pub­lic in­vestors to Bi­cy­cle Ther­a­peu­tics …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.